Experts have issued a warning over itchy skin and other symptoms as it could be a sign of a rare type of cancer.

The U.S. Food and Drug Administration has approved Zevaskyn for patients suffering from rare, genetic skin disease recessive ...

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life ...

A young Indonesian man is warning fellow shoppers to make sure they wash their thrift store clothes after he was left with ...

The U.S. Food and Drug Administration (FDA) has approved Abeona Therapeutics Inc.’s ZEVASKYN gene-modified cellular sheets.

Researchers have developed a skin-based test that can detect misfolded tau proteins specific to progressive supranuclear ...

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

People with xeroderma pigmentosum can severely burn within minutes of being in the sun and are thousands of times more likely ...

With FDA approval, Zevaskyn is set to be a game-changer in the treatment of recessive dystrophic epidermolysis ...

Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can ...

The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic ...